Lithium: a versatile tool for understanding renal physiology
- PMID: 23408166
- PMCID: PMC3651632
- DOI: 10.1152/ajprenal.00718.2012
Lithium: a versatile tool for understanding renal physiology
Abstract
By virtue of its unique interactions with kidney cells, lithium became an important research tool in renal physiology and pathophysiology. Investigators have uncovered the intricate relationships of lithium with the vasopressin and aldosterone systems, and the membrane channels or transporters regulated by them. While doing so, their work has also led to 1) questioning the role of adenylyl cyclase activity and prostaglandins in lithium-induced suppression of aquaporin-2 gene transcription; 2) unraveling the role of purinergic signaling in lithium-induced polyuria; and 3) highlighting the importance of the epithelial sodium channel (ENaC) in lithium-induced nephrogenic diabetes insipidus (NDI). Lithium-induced remodeling of the collecting duct has the potential to shed new light on collecting duct remodeling in disease conditions, such as diabetes insipidus. The finding that lithium inhibits glycogen synthase kinase-3β (GSK3β) has opened an avenue for studies on the role of GSK3β in urinary concentration, and GSK isoforms in renal development. Finally, proteomic and metabolomic profiling of the kidney and urine in rats treated with lithium is providing insights into how the kidney adapts its metabolism in conditions such as acquired NDI and the multifactorial nature of lithium-induced NDI. This review provides state-of-the-art knowledge of lithium as a versatile tool for understanding the molecular physiology of the kidney, and a comprehensive view of how this tool is challenging some of our long-standing concepts in renal physiology, often with paradigm shifts, and presenting paradoxical situations in renal pathophysiology. In addition, this review points to future directions in research where lithium can lead the renal community.
Keywords: aldosterone; arginine vasopressin; diabetes insipidus; glycogen synthase kinase-3; prostaglandins; purinergic signaling.
Similar articles
-
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.Acta Physiol (Oxf). 2015 Jun;214(2):176-88. doi: 10.1111/apha.12507. Epub 2015 May 4. Acta Physiol (Oxf). 2015. PMID: 25877068 Free PMC article. Review.
-
Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria.Am J Physiol Renal Physiol. 2005 Apr;288(4):F642-9. doi: 10.1152/ajprenal.00287.2004. Epub 2004 Dec 7. Am J Physiol Renal Physiol. 2005. PMID: 15585669
-
Lithium reduces aquaporin-2 transcription independent of prostaglandins.Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C131-40. doi: 10.1152/ajpcell.00197.2011. Epub 2011 Aug 31. Am J Physiol Cell Physiol. 2012. PMID: 21881002
-
Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings.J Nephrol. 2010 Nov-Dec;23 Suppl 16:S43-8. J Nephrol. 2010. PMID: 21170888 Review.
-
P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.J Am Soc Nephrol. 2015 Dec;26(12):2978-87. doi: 10.1681/ASN.2014010118. Epub 2015 Apr 8. J Am Soc Nephrol. 2015. PMID: 25855780 Free PMC article.
Cited by
-
Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus.PLoS One. 2014 Jul 9;9(7):e101753. doi: 10.1371/journal.pone.0101753. eCollection 2014. PLoS One. 2014. PMID: 25006961 Free PMC article.
-
The soluble (Pro) renin receptor does not influence lithium-induced diabetes insipidus but does provoke beiging of white adipose tissue in mice.Physiol Rep. 2017 Nov;5(21):e13410. doi: 10.14814/phy2.13410. Physiol Rep. 2017. PMID: 29138356 Free PMC article.
-
Nocturnal enuresis associated with lithium carbonate extended-release tablets in a girl with major depressive disorder: A case report.Medicine (Baltimore). 2025 May 16;104(20):e42505. doi: 10.1097/MD.0000000000042505. Medicine (Baltimore). 2025. PMID: 40388749 Free PMC article.
-
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.Acta Physiol (Oxf). 2015 Jun;214(2):176-88. doi: 10.1111/apha.12507. Epub 2015 May 4. Acta Physiol (Oxf). 2015. PMID: 25877068 Free PMC article. Review.
-
Editorial: Insights in renal and epithelial physiology: 2023.Front Physiol. 2024 Dec 10;15:1523820. doi: 10.3389/fphys.2024.1523820. eCollection 2024. Front Physiol. 2024. PMID: 39720315 Free PMC article. No abstract available.
References
-
- Allen HM, Jackson RL, Winchester MD, Deck LV, Allon M. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med 149: 1123–1126, 1989 - PubMed
-
- Baer L, Glassman AH, Kassir S. Negative sodium balance in lithium carbonate toxicity. Evidence of mineralocorticoid blockade. Arch Gen Psychiatry 29: 823–827, 1973 - PubMed
-
- Baldenssarini RJ, Pompili M, Tondo L. Suicide in bipolar disorder: risks and management. CNS Spectr 11: 465–471, 2006 - PubMed
-
- Bedford JJ, Leader JP, Jing R, Walker LJ, Klein JD, Sands JM, Walker RJ. Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 294: F812–F820, 2008 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous